Advertisement

Related Videos

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Opening Session Panel Discussion

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Nov
19
Today In Oncology
New Computational Tool Shows Strong Accuracy in Predicting Cancer Drug Targets
Long-Term Survival With vs Without Postmastectomy Chest Wall Irradiation in Breast Cancer
Newly Diagnosed AL Amyloidosis FDA Grants Traditional Approval to Regimen
Curative Treatment After First-Line Immunotherapy Improves Survival in HCC
FDA Approves Selumetinib for Adults With NF1 With Symptomatic, Inoperable Plexiform Neurofibromas
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo